Bernard–Soulier syndrome

From WikiMD's WELLNESSPEDIA

(Redirected from Bernard-soulier syndrome)

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Bernard–Soulier syndrome
Synonyms Hemorrhagiparous thrombocytic dystrophy
Pronounce
Specialty Hematology
Symptoms Prolonged bleeding, easy bruising, nosebleeds, menorrhagia
Complications N/A
Onset
Duration
Types
Causes Genetic mutation in the GPIb-IX-V complex
Risks
Diagnosis Blood test, platelet aggregation test, flow cytometry
Differential diagnosis von Willebrand disease, Glanzmann's thrombasthenia
Prevention
Treatment Platelet transfusion, antifibrinolytic agents
Medication
Prognosis
Frequency Rare
Deaths


File:WVSOM Megakaryocytes arrows.jpg
Bernard–Soulier syndrome
File:Tranexam.svg
Bernard–Soulier syndrome

Bernard–Soulier syndrome (also termed Bernard–Soulier disease, hemorrhagiparous thrombocytic dystrophy, giant platelet syndrome, and von Willebrand disease type B) is a rare inherited bleeding disorder that affects the platelets. It is characterized by unusually large platelets, a low number of platelets, and prolonged bleeding time. The syndrome is caused by a deficiency or dysfunction of the glycoprotein Ib-IX-V complex, a platelet membrane protein that is critical for platelet adhesion to the subendothelium.

Symptoms[edit]

The symptoms of Bernard–Soulier syndrome typically include easy bruising, nosebleeds, and prolonged bleeding after injury or surgery. Women with this condition may experience heavy menstrual bleeding. The severity of the bleeding symptoms can vary among affected individuals.

Causes[edit]

Bernard–Soulier syndrome is caused by mutations in the GP1BA, GP1BB, or GP9 genes. These genes provide instructions for making parts of the glycoprotein Ib-IX-V complex. This complex binds to a protein called von Willebrand factor, a critical step in the formation of blood clots. Mutations in the GP1BA, GP1BB, or GP9 genes reduce the number of glycoprotein Ib-IX-V complexes or alter their structure, impairing the ability of platelets to stick to the site of a wound and form a clot.

Diagnosis[edit]

The diagnosis of Bernard–Soulier syndrome is based on the clinical symptoms, a complete blood count, blood smear examination, and specialized platelet function tests. Genetic testing can confirm the diagnosis.

Treatment[edit]

There is no cure for Bernard–Soulier syndrome. Treatment is aimed at controlling bleeding episodes, which may include platelet transfusions, antifibrinolytic drugs, and desmopressin.

See also[edit]

References[edit]